The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Feb. 28, 2018
Applicant:

Saint Joseph's University, Philadelphia, PA (US);

Inventor:

Zachary A. Klase, Sewell, NJ (US);

Assignee:

Saint Joseph's University, Philadelphia, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5513 (2006.01); A61P 31/18 (2006.01); A61K 31/165 (2006.01); A61K 31/167 (2006.01); A61K 31/404 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5513 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/404 (2013.01); A61P 31/18 (2018.01);
Abstract

The present invention relates in part to the discovery that benzodiazepines can be used to reactivate latent HIV-1 virus that is integrated into human genome. In other embodiments, the benzodiazepine is used in combination with a histone deacetylase inhibitor (HDACi), such as but not limited to SAHA (also known as N-hydroxy-N-phenyl-octanediamide, Suberoylanilide hydroxamic acid, Vorinostat). In yet other embodiments, the combination of benzodiazepine and the HDACi synergistically reactivates latent HIV-1 virus that is integrated into human genome, with minimal or no significant toxicity associated with the dose of either agent.


Find Patent Forward Citations

Loading…